Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ischemic Heart Disease

  Free Subscription


06.10.2025

19 Am J Cardiol
3 Am J Med
1 Angiology
2 Arterioscler Thromb Vasc Biol
1 Can J Cardiol
2 Cardiovasc Res
1 Circ Arrhythm Electrophysiol
4 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
2 Circ J
6 Circulation
11 Curr Opin Cardiol
2 Heart
3 J Am Coll Cardiol
1 J Clin Epidemiol
1 J Clin Invest
3 J Mol Cell Cardiol
2 J Thorac Cardiovasc Surg
1 J Thromb Haemost
2 Mayo Clin Proc
5 N Engl J Med
2 PLoS One
1 Prog Cardiovasc Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. LIU L, Ma H, Yang S, Yu C, et al
    The Role of Lipoprotein(a) in Cardiovascular Risk Stratification: IntegratingLow-density Lipoprotein Cholesterol and Polygenic Risk Scores.
    Am J Cardiol. 2025 Sep 24:S0002-9149(25)00562.
    PubMed         Abstract available

  2. KYRIAKOULIS I, Nanna MG, Rao-Brito M, Cambi B, et al
    The additive value of FFR-CT in the evaluation of calcified coronary arteries with Coronary CT Angiography.
    Am J Cardiol. 2025 Sep 25:S0002-9149(25)00578.
    PubMed         Abstract available

  3. HUEI-YING L, Wang J
    Lipoprotein(a) levels are not predictive of baseline cardiovascular comorbidity risk in adults with peripheral arterial disease.
    Am J Cardiol. 2025 Sep 26:S0002-9149(25)00594.
    PubMed        

  4. TAWFIK JA, Budoff M
    Colchicine in Coronary Artery Disease: A Contemporary Review of Evidence from Clinical Outcomes and Imaging Trials.
    Am J Cardiol. 2025 Sep 26:S0002-9149(25)00589.
    PubMed         Abstract available

  5. SHUJA SH, Shuja MH, Shaukat A, Hannat R, et al
    GLP-1 Receptor Agonists and Cardiovascular Outcomes in Adults with Diabetes and Peripheral Artery Disease: An Updated Systematic Review and Meta-Analysis.
    Am J Cardiol. 2025 Sep 27:S0002-9149(25)00595.
    PubMed         Abstract available

  6. ODAGIRI S, Motozawa Y, Hashimoto S
    Survey Study to Differentiate Vasospastic Angina from Coronary Microvascular Dysfunction in Real-World Management of Ischemia with Non-Obstructive Coronary Artery Disease.
    Am J Cardiol. 2025 Sep 27:S0002-9149(25)00584.
    PubMed         Abstract available

  7. AKBAR UA, Alruwaili W, Lacoste JL, Thyagaturu H, et al
    Comparative Effectiveness of Prasugrel versus Ticagrelor in Dialysis-Dependent end stage renal disease Patients Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2025 Sep 27:S0002-9149(25)00588.
    PubMed         Abstract available

  8. GUPTA S, Ahimsadasan N, Dalsania K, Jing L, et al
    Alcohol and Cardiovascular Disease.
    Am J Cardiol. 2025 Sep 28:S0002-9149(25)00590.
    PubMed         Abstract available

  9. SEDRAKYAN S, Nadeem B, Gaughran D, Sinauridze A, et al
    Bridging Gaps in LDL-C Management: Utilization of Lipid-Lowering Therapies, Gender Disparities, and the Impact of Cardiology Visits on Secondary Prevention.
    Am J Cardiol. 2025;253:1-9.
    PubMed         Abstract available

  10. CAU R, Onnis C, Pontone G, Guglielmo M, et al
    CMR-derived atrial strain in the prediction of adverse cerebrovascular events after myocardial infarction.
    Am J Cardiol. 2025 Sep 22:S0002-9149(25)00568.
    PubMed         Abstract available

  11. SEDHOM R, Omer M, Khedr M, Abramov D, et al
    Characteristics and Outcomes of ST-Segment Elevation Myocardial Infarction due to Left Main Coronary Artery Stenosis.
    Am J Cardiol. 2025 Sep 22:S0002-9149(25)00563.
    PubMed         Abstract available

  12. IMBODEN MT, Koltner E, Bryant JH, Jones A, et al
    Sex Disparities in Acute Myocardial Infarction Diagnosis and Treatment.
    Am J Cardiol. 2025 Sep 22:S0002-9149(25)00567.
    PubMed         Abstract available

  13. NDREPEPA G
    Acute Myocardial Infarction with High Thrombus Burden: Improved Outcomes with Intravascular Imaging-Guided Percutaneous Coronary intervention.
    Am J Cardiol. 2025 Sep 26:S0002-9149(25)00591.
    PubMed        

  14. LI J, Zhang Y, Ma Y, Sun J, et al
    Causes of In-Hospital Death in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Beijing Area.
    Am J Cardiol. 2025 Sep 27:S0002-9149(25)00585.
    PubMed         Abstract available

  15. NISHIKAWA R, Shiomi H, Yamamoto K, Morimoto T, et al
    Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort.
    Am J Cardiol. 2025 Sep 24:S0002-9149(25)00574.
    PubMed         Abstract available

  16. PASSEY S, Jha J, Iverson M, Zhong K, et al
    Angiographic Characteristics and Associated Risk Factors of Premature Coronary Artery Disease among South Asians: A Systematic Review.
    Am J Cardiol. 2025 Sep 24:S0002-9149(25)00569.
    PubMed         Abstract available

  17. GRASSI G, Ram CVS, Palatini P
    High Heart Rate, Sympathetic Overdrive, And Cardiovascular Risk In Hypertension.
    Am J Cardiol. 2025 Sep 23:S0002-9149(25)00576.
    PubMed         Abstract available

  18. JONES JE, Patel RC, Stouffer GA
    Primary percutaneous coronary intervention is associated with improved survival for inpatient-onset STEMI across all age groups.
    Am J Cardiol. 2025 Sep 22:S0002-9149(25)00571.
    PubMed        

  19. AL-HOLY A, Comanici M, Das A, Marczin N, et al
    Single Arterial versus Multiple Arterial Grafting in 3,164 Diabetic Patients Undergoing Coronary Artery Bypass Surgery: A Propensity-Matched Analysis.
    Am J Cardiol. 2025 Sep 22:S0002-9149(25)00572.
    PubMed         Abstract available


    Am J Med

  20. AHMED M, Rana JS, Ahmed R, Fonarow GC, et al
    Oral anticoagulant monotherapy in patients with chronic coronary disease: An updated meta-analysis.
    Am J Med. 2025 Sep 25:S0002-9343(25)00631-X. doi: 10.1016/j.amjmed.2025.
    PubMed         Abstract available

  21. GRINBERG T, Aviv Y, Shiyovich A, Vronsky D, et al
    Coronary Artery Disease Characterization and Plaque Morphology in Patients with Hypertrophic Cardiomyopathy.
    Am J Med. 2025 Sep 25:S0002-9343(25)00619-9. doi: 10.1016/j.amjmed.2025.
    PubMed         Abstract available

  22. AJMAL M, Javed A, Corban MT
    Cardiovascular Care in Rural America: Challenges, Insights, and Strategies for Meaningful Improvement.
    Am J Med. 2025 Sep 25:S0002-9343(25)00624-2. doi: 10.1016/j.amjmed.2025.
    PubMed        


    Angiology

  23. AKGUL A, Tunca C, Tas A, Ayli MD, et al
    Association of Serum Uric Acid and CRP/Albumin Ratio With Contrast-Induced Nephropathy in Acute Myocardial Infarction Patients.
    Angiology. 2025 Sep 29:33197251376082. doi: 10.1177/00033197251376082.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  24. CHO DI, Ahn JH, Kang BG, Hwang I, et al
    ANGPTL4 Prevents Atherosclerosis by Preserving KLF2 to Suppress EndMT and Mitigates Endothelial Dysfunction.
    Arterioscler Thromb Vasc Biol. 2025;45:1742-1761.
    PubMed         Abstract available

  25. REIJNDERS E, Bossuyt P, Jukema JW, Ruhaak LR, et al
    Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.
    Arterioscler Thromb Vasc Biol. 2025 Sep 25. doi: 10.1161/ATVBAHA.124.322336.
    PubMed         Abstract available


    Can J Cardiol

  26. GHAFFAR MD, Javed MU
    Reassessing the Clinical Applicability of Artificial Intelligence Driven Risk Models in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Sep 27:S0828-282X(25)01188.
    PubMed        


    Cardiovasc Res

  27. NOONAN J, Prijaya SA, Bienvenu LA, Dayawansa NH, et al
    CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion.
    Cardiovasc Res. 2025 Oct 3:cvaf165. doi: 10.1093.
    PubMed         Abstract available

  28. GOLFOROUSH P, Sulaiman E, He D, Yellon DM, et al
    An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia/reperfusion injury in mice with coronary atherosclerosis or insulin resistance.
    Cardiovasc Res. 2025;121:1722-1733.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  29. ZHOU Z, Zhang H, Xiong H, Deng KQ, et al
    Inhibition of Satellite Glial Cell Activation in Stellate Ganglia Prevents Ventricular Arrhythmogenesis and Remodeling After Myocardial Infarction.
    Circ Arrhythm Electrophysiol. 2025 Sep 30:e013866.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  30. JESSNEY B, Chen X, Gu S, Huang Y, et al
    Artificial Intelligence-Led Whole Coronary Artery OCT Analysis; Validation and Identification of Drug Efficacy and Higher-Risk Plaques.
    Circ Cardiovasc Imaging. 2025 Sep 25:e018133.
    PubMed         Abstract available

  31. XU B, Al Zein M
    Fully Automated Artificial Intelligence-Based Global Longitudinal and Circumferential Strain for Prediction of Cardiovascular Events: Unleash the Power of Stress CMR.
    Circ Cardiovasc Imaging. 2025 Sep 29:e019010.
    PubMed        

  32. SAYAMA K, Kanaji Y, Usui E, Hada M, et al
    Increasing Extracellular Volume Fraction on Coronary CTA in Patients With Coronary Microvascular Dysfunction.
    Circ Cardiovasc Imaging. 2025 Sep 30:e018368.
    PubMed         Abstract available

  33. MELVINSDOTTIR IH, Midgett D, Lee SR, Thorn SL, et al
    Intramyocardial Hydrogel Delivery Decreases Left Ventricular Remodeling and Increases Angiogenesis Post Myocardial Infarction.
    Circ Cardiovasc Imaging. 2025 Sep 29:e018357.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  34. SARTI A, Erriquez A, Dal Passo B, Casella G, et al
    Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions.
    Circ Cardiovasc Interv. 2025 Oct 3:e015902.
    PubMed         Abstract available


    Circ J

  35. KURITA T, Hirota Y, Mori H, Kirii Y, et al
    Prehospital Vital Signs, Including SpO(2), Are Significantly Associated With Mortality and Mechanical Circulatory Support Requirement in Acute Myocardial Infarction Patients.
    Circ J. 2025 Sep 30. doi: 10.1253/circj.CJ-25-0584.
    PubMed         Abstract available

  36. KAWAKAMI S, Nakashima T
    Go to the Emergency Department?- Early Cardiologist Engagement in Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Circ J. 2025 Sep 23. doi: 10.1253/circj.CJ-25-0668.
    PubMed        


    Circulation

  37. VONGPATANASIN W, Abraham J, Giacona JM
    Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
    Circulation. 2025;152:924-926.
    PubMed        

  38. SECHI LA, Bulfone L, Catena C
    Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e265-e266.
    PubMed        

  39. BHATIA HS, Tsimikas S
    Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e267-e268.
    PubMed        

  40. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
    PubMed         Abstract available

  41. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
    Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
    PubMed         Abstract available

  42. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
    Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
    Circulation. 2025;152:971-973.
    PubMed        


    Curr Opin Cardiol

  43. BERNSTEIN HM, Reddy RK, Boskovski M, Ahmad Y, et al
    Ischemic events after coronary artery bypass grafting: when to treat interventionally, medically or surgically?
    Curr Opin Cardiol. 2025;40:399-405.
    PubMed         Abstract available

  44. BOSKOVSKI MT, Tseng EE
    Completed and ongoing trials in minimally invasive cardiac surgery coronary surgery.
    Curr Opin Cardiol. 2025;40:406-409.
    PubMed         Abstract available

  45. NOGAMI K, Lerman LO, Lerman A
    The clinical utility of assessing coronary vasomotor dysfunction in angina with nonobstructive coronary artery.
    Curr Opin Cardiol. 2025;40:440-447.
    PubMed         Abstract available

  46. KINOSHITA D, Watanabe M, Jang IK
    The role of high-risk plaque in refining cardiovascular event prediction.
    Curr Opin Cardiol. 2025;40:432-439.
    PubMed         Abstract available

  47. MILOJEVIC M, Micovic S, Otasevic P
    Invasive treatment strategies in the ESC guidelines developed in collaboration with EACTS for the management of chronic coronary syndrome: implications for contemporary clinical practice.
    Curr Opin Cardiol. 2025;40:382-389.
    PubMed         Abstract available

  48. REDDY RK, Bernstein H, Howard JP, Ahmad Y, et al
    Complete revascularization with percutaneous coronary intervention for acute coronary syndromes presenting with multivessel disease.
    Curr Opin Cardiol. 2025;40:410-416.
    PubMed         Abstract available

  49. CHOTAI S, Chiew K, Al-Lamee R
    Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots.
    Curr Opin Cardiol. 2025;40:417-423.
    PubMed         Abstract available

  50. GOUBRAN D, Issa H, Clarizia N, Chan V, et al
    Postmyocardial infarction ventricular septal rupture: optimizing surgical timing and repair.
    Curr Opin Cardiol. 2025;40:395-398.
    PubMed         Abstract available

  51. SARFARAZ ZK, Abri QA, Ramchandani M
    Teaching minimally invasive coronary artery bypass grafting: a structured framework for well tolerated adoption and training.
    Curr Opin Cardiol. 2025;40:390-394.
    PubMed         Abstract available

  52. AUN JA, Blair CV, Blankstein R, Weber BN, et al
    Advanced cardiovascular imaging in immune-mediated inflammatory diseases: redefining ischemic heart disease risk.
    Curr Opin Cardiol. 2025;40:424-431.
    PubMed         Abstract available

  53. KWONG RY, Heydari B, Bernhard B
    A practical review of stress perfusion cardiac magnetic resonance imaging for the management of coronary artery disease.
    Curr Opin Cardiol. 2025;40:448-458.
    PubMed         Abstract available


    Heart

  54. DESROCHE LM, Darmon A, Lavie-Badie Y, Mandry D, et al
    Diagnostic accuracy of late gadolinium enhancement cardiac MRI for coronary artery disease in patients with reduced left ventricular ejection fraction.
    Heart. 2025 Mar 27:heartjnl-2024-325419. doi: 10.1136/heartjnl-2024-325419.
    PubMed         Abstract available

  55. DI MURO FM, Sartori S, Vogel B, Lupo S, et al
    Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary intervention.
    Heart. 2025 Mar 21:heartjnl-2024-325396. doi: 10.1136/heartjnl-2024-325396.
    PubMed         Abstract available


    J Am Coll Cardiol

  56. LEE H, Huang X, Khan SS, Son D, et al
    Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease.
    J Am Coll Cardiol. 2025;86:1017-1029.
    PubMed         Abstract available

  57. MENSAH GA, Arnold N, Prabhu SD, Ridker PM, et al
    Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.
    J Am Coll Cardiol. 2025 Sep 29:S0735-1097(25)07555.
    PubMed         Abstract available

  58. BERMAN AN, Mukhopadhyay A, Blecker SB, Horwitz LI, et al
    Reimagining Cardiovascular Screening: Leveraging Detection for Population Health Impact.
    J Am Coll Cardiol. 2025;86:959-961.
    PubMed        


    J Clin Epidemiol

  59. HTOO PT, Paik JM, Everett BM, Glynn RJ, et al
    Machine Learning For Predicting Cardiovascular Events In Older Adults With Type 2 Diabetes Using Medicare Claims And Electronic Health Records.
    J Clin Epidemiol. 2025 Sep 26:112001. doi: 10.1016/j.jclinepi.2025.112001.
    PubMed         Abstract available


    J Clin Invest

  60. NISHIYAMA N, Koizumi H, Nakahashi-Oda C, Fujiyama S, et al
    Immunoreceptor CD300a regulates ischemic tissue damage and adverse remodeling in the mouse heart and kidney.
    J Clin Invest. 2025;135:e184984.
    PubMed         Abstract available


    J Mol Cell Cardiol

  61. ALI SR, Nguyen NUN, Elhelaly W, Hsu CC, et al
    Paracrine IGFBP3 spatially coordinates IGF signaling to induce myocardial regeneration in mice.
    J Mol Cell Cardiol. 2025;207:93-106.
    PubMed         Abstract available

  62. THOMAS D, Yang PC, Wu JC, Sayed N, et al
    Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies.
    J Mol Cell Cardiol. 2025 Sep 30:S0022-2828(25)00178.
    PubMed         Abstract available

  63. CHOI JS, Pervin M, Vince JE, Sharma A, et al
    Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases.
    J Mol Cell Cardiol. 2025;209:1-14.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  64. MANYAM R, Lou P, Shen HJ, Liu Z, et al
    Interpretable Artificial Intelligence to Predict Preoperative Risk Factors for Failure to Rescue after Coronary Artery Bypass Grafting.
    J Thorac Cardiovasc Surg. 2025 Sep 30:S0022-5223(25)00850.
    PubMed         Abstract available

  65. IACONA GM, Bakhos JJ, Houghtaling PL, Tipton AE, et al
    Multiarterial grafting in redo coronary artery bypass grafting: Type of arterial conduit and patient sex determine benefit.
    J Thorac Cardiovasc Surg. 2025;170:1079-1086.
    PubMed         Abstract available


    J Thromb Haemost

  66. COUGHLAN JJ, Durand R, Birrane J, Blackburne B, et al
    A history of the development of dual antiplatelet therapy for coronary artery disease.
    J Thromb Haemost. 2025;23:3336-3348.
    PubMed         Abstract available


    Mayo Clin Proc

  67. MOON IT, Park YK, Yi HJ, Chun HJ, et al
    Long-term Outcomes of Hypertension and Antihypertensive Drugs in Healthy Young Adults: A Nationwide Population-Based Prospective Cohort Study in Korea.
    Mayo Clin Proc. 2025;100:1758-1770.
    PubMed         Abstract available

  68. ZAHID S, Peng AW, Razavi AC, Yao Z, et al
    Does the New Clinical Obesity Definition Address the Obesity Paradox in Cardiovascular Health?
    Mayo Clin Proc. 2025 Sep 30:S0025-6196(25)00397.
    PubMed        


    N Engl J Med

  69. MAGNUSSEN C, Lorenz T, Blankenberg S
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. Reply.
    N Engl J Med. 2025;393:1247-1248.
    PubMed        

  70. CORDERO L, Abasheva D, Ortiz A
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025;393:1246-1247.
    PubMed        

  71. AKBARPOUR S, Azizpour Y, Larijani B
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025;393:1246.
    PubMed        

  72. ZHENG X, Zhang J, Li Z
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025;393:1245-1246.
    PubMed        

  73. COOPER KH
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025;393:1245.
    PubMed        


    PLoS One

  74. HERTZ JT, Sakita FM, Haukila KF, Shayo PS, et al
    Acceptability and feasibility of a multicomponent intervention to improve acute myocardial infarction care in Northern Tanzania: The MIMIC pilot trial.
    PLoS One. 2025;20:e0333271.
    PubMed         Abstract available

  75. JIANG Y, Li X, He X, Hu H, et al
    The specificity for the correlation between viscera and somato in chronic stable angina pectoris patients and healthy controls: An assessor-blinded and comparative trial.
    PLoS One. 2025;20:e0331868.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  76. POLO-LOPEZ A, Andersen LL, Nunez-Cortes R, Lopez-Bueno R, et al
    Handgrip strength asymmetry increases risk of all-cause and cardiovascular mortality: A dose-response analysis across 28 countries.
    Prog Cardiovasc Dis. 2025 Sep 30:S0033-0620(25)00146.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.